The Beginning of $iBio - Admiral Brett Girior on a Conference in 2012 In this video, Admiral Dr. Brett Giroir speaks at a TEDxSMU conference in 2012 about the efforts being made to improve the nation's emergency preparedness against emerging infectious diseases, including pandemic influenza. His remarks and thoughts on this topic were forward-looking and have now become reality.Admiral Brett Giroir, United States Assistant Secretary for Health designed iBio's facility for project GreenVax in 2011. iBio, Inc. (NYSE MKT: IBIO), a leader in the plant-made pharmaceutical field, develops and offers pharmaceutical product applications using its iBio Technology platform. The iBio Technology platform is a proprietary, transformative technology for the production of biologics including monoclonal antibodies, other therapeutic proteins and vaccines. In 2012, Dr. Brett Giroir was Vice Chancellor for Strategic Initiatives for the Texas A&M University System and Principal Investigator for the Texas A&M Center for Innovation in Advanced Development and Manufacturing, a public-private partnership with the U.S. Department of Health and Human Services designed to enhance the nation's emergency preparedness against emerging infectious diseases, including pandemic influenza, and chemical, biological, radiological and nuclear threats.
About TEDx: In the spirit of ideas worth spreading, TEDx is a program of local, self-organized events that bring people together to share a TED-like experience. At a TEDx event, TEDTalks video and live speakers combine to spark deep discussion and connection in a small group. These local, self-organized events are branded TEDx, where x = independently organized TED event. The TED Conference provides general guidance for the TEDx program, but individual TEDx events are self-organized.* (*Subject to certain rules and regulations).
About Admiral Brett P. Giroir: Brett P. Giroir (pronounced as jir-WAH) (born November 4, 1960) is an American pediatrician and a four-star admiral in the U.S. Public Health Service Commissioned Corps. In February 2018 he was appointed Assistant Secretary for Health under the Trump administration. He concurrently serves as the Secretary's principal public health and science adviser, the senior adviser for the Health Resources and Services Administration, the Centers for Disease Control and Prevention, and the Substance Abuse and Mental Health Services Administration as well as the Senior Adviser to the Secretary for Opioid Policy. In 2020, he assumed the additional roles of the director of the U.S. coronavirus diagnostic testing, and the U.S. representative on the World Health Organization Executive Board. He stepped down as director of the U.S. coronavirus diagnostic testing to return to his primary duties as assistant secretary for health in mid-June 2020. https://en.wikipedia.org/wiki/Brett_Giroir
About iBio Inc.: iBio, Inc. (NYSE MKT: IBIO), a leader in the plant-made pharmaceutical field, develops and offers pharmaceutical product applications using its iBio Technology platform. The iBio Technology platform is a proprietary, transformative technology for the production of biologics including monoclonal antibodies, other therapeutic proteins and vaccines. https://www.ibioinc.com/
Market Data 
Markets 
AI
